| Mr Robert A Schoenfelder, CRNA | |
|
2720 Stone Park Blvd, Sioux City, IA 51104-3734 | |
| (712) 279-3290 | |
| Not Available |
| Full Name | Mr Robert A Schoenfelder |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 2720 Stone Park Blvd, Sioux City, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104863240 | NPI | - | NPPES |
| 0123695 | Medicaid | IA | |
| 0123802 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R014513 (South Dakota) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | D-053906 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Robert A Schoenfelder, CRNA Po Box 683, Sioux City, IA 51102-0683 Ph: (712) 279-3290 | Mr Robert A Schoenfelder, CRNA 2720 Stone Park Blvd, Sioux City, IA 51104-3734 Ph: (712) 279-3290 |
News Archive
In a recent study published on the pre-print bioRxiv* server, a group of Israeli researchers discusses their progress towards developing an oral multi-antigen SARS-CoV-2 vaccine.
In a medical case of Jekyll and Hyde, carbon monoxide - the highly toxic gas emitted from auto exhausts and faulty heating systems - has proven effective in treating the symptoms of pulmonary arterial hypertension (PAH), an extremely debilitating condition that typically leads to right heart failure and eventual death.
Cadence Pharmaceuticals, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) approved dosing recommendations for OFIRMEV (acetaminophen) injection remains 4,000 mg per day for adults and adolescents weighing at least 50 kg.
Chelsea Therapeutics International, Ltd. announced it has completed a pre-NDA assessment with the U.S. Food and Drug Administration (FDA) and intends to accelerate its new drug application (NDA) for NORTHERA™(droxidopa) for the treatment of symptomatic, neurogenic orthostatic hypotension (NOH), a chronic and potentially debilitating drop in blood pressure upon standing commonly associated Parkinson's disease, multiple system atrophy and pure autonomic failure.
Optimer Pharmaceuticals, Inc. today announced that it has submitted the first section of a rolling New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for fidaxomicin to treat patients with Clostridium difficile infection (CDI) and to prevent recurrences of CDI. Optimer anticipates completing the submission in the fourth quarter of 2010 and plans to request priority review, which, if granted, could lead to an FDA decision on the NDA in the second quarter of 2011.
› Verified 9 days ago
Lance D Breit, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2720 Stone Park Blvd, Sioux City, IA 51104 Phone: 712-255-2324 | |
Robert Baczwaski, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2720 Stone Park Blvd, Sioux City, IA 51104 Phone: 712-255-2324 | |
Raichatou Ann Jackson, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2720 Stone Park Blvd, Sioux City, IA 51104 Phone: 712-279-3500 | |
Patrick Menke, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2720 Stone Park Blvd, Sioux City, IA 51104 Phone: 712-279-3500 | |
Deborah Carter, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 801 5th St, Sioux City, IA 51101 Phone: 712-279-2505 | |
Dr. Jared Gregory Feiner, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2720 Stone Park Blvd, Sioux City, IA 51104 Phone: 712-279-3500 |